Cancer Stories
Didn't see your exact story?
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Clara was 24 when symptoms that seemed unrelated slowly pointed to something serious. Hip and back pain were first explained as an L5-S1 herniated disc from running, but the pain around that area later made more sense after doctors found cancer had spread to her bones and joints. She also noticed a breast lump, dizziness and fainting spells, unexplained weight loss, neuropathy, headaches, swollen lymph nodes, and severe anemia. Because she did not have typical respiratory symptoms, lung cancer was not what she expected. A CT scan in the emergency room showed widespread cancer, and doctors explained that it had already spread to other organs. An MRI later showed brain metastases, so treatment began with brain radiation right away. A biopsy from a liver lesion or left-liver site found a biomarker that helped guide treatment, but the specific mutation was not named. Her first-line systemic treatment used 2 chemotherapy drugs plus immunotherapy at the same time. She then continued immunotherapy, which she described as treatment she would stay on for the rest of her life. Clinical trials were discussed, and her oncologist said she qualified for some, but she chose to continue first-line treatment first. As of August 2025, Clara was living with Stage IV metastatic lung cancer, using a cane or walker at times, relying on support, and learning how to live with lifelong care.
This is a lay summary of an account first published by The Patient Story. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer